167 related articles for article (PubMed ID: 38851590)
1. In vivo deposition of poorly soluble drugs.
Lou Z; Mu C; Corpstein CD; Li T
Adv Drug Deliv Rev; 2024 Jun; 211():115358. PubMed ID: 38851590
[TBL] [Abstract][Full Text] [Related]
2. The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.
Khan J; Rades T; Boyd B
Pharm Res; 2016 Mar; 33(3):548-62. PubMed ID: 26597939
[TBL] [Abstract][Full Text] [Related]
3. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
[TBL] [Abstract][Full Text] [Related]
4. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
[TBL] [Abstract][Full Text] [Related]
5. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
Kataoka M; Masaoka Y; Yamazaki Y; Sakane T; Sezaki H; Yamashita S
Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulations.
Kollipara S; Gandhi RK
Acta Pharm Sin B; 2014 Oct; 4(5):333-49. PubMed ID: 26579403
[TBL] [Abstract][Full Text] [Related]
7. Lipid-Based Formulations Can Enable the Model Poorly Water-Soluble Weakly Basic Drug Cinnarizine To Precipitate in an Amorphous-Salt Form During In Vitro Digestion.
Khan J; Rades T; Boyd BJ
Mol Pharm; 2016 Nov; 13(11):3783-3793. PubMed ID: 27631273
[TBL] [Abstract][Full Text] [Related]
8. Clay-based Formulations for Bioavailability Enhancement of Poorly Water-soluble Drugs.
Tran PHL; Tran TTD
Curr Drug Metab; 2021; 22(9):726-734. PubMed ID: 34151758
[TBL] [Abstract][Full Text] [Related]
9. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
10. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
[TBL] [Abstract][Full Text] [Related]
11. 50years of oral lipid-based formulations: Provenance, progress and future perspectives.
Feeney OM; Crum MF; McEvoy CL; Trevaskis NL; Williams HD; Pouton CW; Charman WN; Bergström CAS; Porter CJH
Adv Drug Deliv Rev; 2016 Jun; 101():167-194. PubMed ID: 27089810
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
Buckley ST; Frank KJ; Fricker G; Brandl M
Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
[TBL] [Abstract][Full Text] [Related]
13. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution.
Mohsin K; Long MA; Pouton CW
J Pharm Sci; 2009 Oct; 98(10):3582-95. PubMed ID: 19130605
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.
Zhang X; Xing H; Zhao Y; Ma Z
Pharmaceutics; 2018 Jun; 10(3):. PubMed ID: 29937483
[TBL] [Abstract][Full Text] [Related]
15. Drug precipitation inhibitors in supersaturable formulations.
Xu S; Dai WG
Int J Pharm; 2013 Aug; 453(1):36-43. PubMed ID: 23680727
[TBL] [Abstract][Full Text] [Related]
16. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
Stewart AM; Grass ME
Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
[TBL] [Abstract][Full Text] [Related]
17. An improved method for the characterization of supersaturation and precipitation of poorly soluble drugs using pulsatile microdialysis (PMD).
Shah KB; Patel PG; Khairuzzaman A; Bellantone RA
Int J Pharm; 2014 Jul; 468(1-2):64-74. PubMed ID: 24709210
[TBL] [Abstract][Full Text] [Related]
18. Potential of Lipid Nanoparticles (SLNs and NLCs) in Enhancing Oral Bioavailability of Drugs with Poor Intestinal Permeability.
Talegaonkar S; Bhattacharyya A
AAPS PharmSciTech; 2019 Feb; 20(3):121. PubMed ID: 30805893
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
20. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
He CX; He ZG; Gao JQ
Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
